Andrea Dempsey
Internal Medicine · Las Vegas, NVNPI 1497879035
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,707 of the $3,096 with a category attached, or 87.4%. 21 manufacturers reported payments, led by Merz North America, Inc. at 38.7% of the total. Reporting peaked in 2019 at $1,301 and has fallen 86.6% since, to $174 in 2023.
Across 116 payments — averaging $26.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$1K
- AbbVie$581
- Novo Nordisk$369
- AstraZeneca$324
- Boehringer Ingelheim$156
- Pfizer$75
- plus $394 from 15 others
What the payments were for
- Speaking & faculty fees$34211%
- Food & beverage$2,70787%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 13 | $1,197 |
| AbbVie(2 entities) | 19 | $581 |
| Novo Nordisk | 27 | $369 |
| AstraZeneca | 15 | $324 |
| Boehringer Ingelheim | 10 | $156 |
| Pfizer | 5 | $75 |
| IBSA Pharma Inc. | 3 | $51 |
| AMAG Pharmaceuticals, Inc. | 4 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $41 |
| Merck | 3 | $40 |
| Astellas Pharma US Inc | 2 | $38 |
| Optinose US, Inc. | 2 | $26 |
| Johnson & Johnson | 2 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Amgen | 1 | $18 |
| Biogen | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| Strongbridge US Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,096 in reported general payments places this provider in the 85th percentile of 1,071 internal medicine providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 51 | $2,616 |
| Liothyronine Sodium | 29 | $886 |
| Pravastatin Sodium | 11 | $173 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Las Vegas
- Kevin DunsmoorLas Vegas$241K
- Robert ChiascioneLas Vegas$174K
- Dino GonzalezLas Vegas$126K
- Rosanne SugayLas Vegas$63K
- Chad HallLas Vegas$42K
- Zubin DamaniaLas Vegas$40K
- Audrey Sue CruzLas Vegas$34K
- Bashab BanerjiLas Vegas$26K
- Amaan ShafiLas Vegas$25K
- Sassan KavehLas Vegas$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.